Varex Imaging (NASDAQ:VREX) Given New $23.00 Price Target at Oppenheimer

Varex Imaging (NASDAQ:VREX) had its price objective lowered by Oppenheimer from $30.00 to $23.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Other equities analysts have also issued research reports about the company. B. Riley restated a “buy” rating and issued a $22.00 price target (up previously from $21.00) on shares of Varex Imaging in a research note on Friday. StockNews.com downgraded Varex Imaging from a “buy” rating to a “hold” rating in a research note on Thursday, January 30th.

Varex Imaging Trading Down 19.3 %

Shares of NASDAQ:VREX opened at $12.27 on Friday. The company has a current ratio of 3.32, a quick ratio of 1.97 and a debt-to-equity ratio of 0.72. The company’s 50 day moving average is $14.54 and its 200 day moving average is $13.39. Varex Imaging has a twelve month low of $10.19 and a twelve month high of $18.30.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 3.96% and a negative net margin of 5.79%. Analysts expect that Varex Imaging will post 0.63 EPS for the current fiscal year.

Hedge Funds Weigh In On Varex Imaging

Hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC raised its holdings in Varex Imaging by 4,739.2% in the 3rd quarter. FMR LLC now owns 200,341 shares of the company’s stock valued at $2,388,000 after acquiring an additional 196,201 shares during the last quarter. Barclays PLC grew its position in shares of Varex Imaging by 15.3% in the third quarter. Barclays PLC now owns 97,883 shares of the company’s stock valued at $1,166,000 after purchasing an additional 12,966 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in shares of Varex Imaging by 37.3% in the third quarter. Assenagon Asset Management S.A. now owns 185,506 shares of the company’s stock valued at $2,211,000 after purchasing an additional 50,382 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in Varex Imaging during the third quarter worth approximately $415,000. Finally, BNP Paribas Financial Markets boosted its stake in Varex Imaging by 1,359.9% during the third quarter. BNP Paribas Financial Markets now owns 52,295 shares of the company’s stock worth $623,000 after buying an additional 48,713 shares during the last quarter.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.